Topic
Xanthone
About: Xanthone is a research topic. Over the lifetime, 1639 publications have been published within this topic receiving 25870 citations. The topic is also known as: 9-oxo-xanthene & Diphenyline ketone oxide.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In an antibacterial assay using a panel of multidrug-resistant (MDR) strains, compounds 3 and 4 exhibited promising activity against the NorA efflux protein overexpressing MDR Staphylococcus aureus strain SA-1199B with a minimum inhibitory concentration (MIC) of 2 μg/mL.
Abstract: Two new norlignans, hyperiones A (1) and B (2), three new acylphloroglucinols, aspidinol C (3) and hyperaspidinols A (5) and B (6), the known compound aspidinol D (4), and the symmetrical dimeric xanthone hyperidixanthone (7) were isolated from Hypericum chinense Their structures were established by spectroscopic analysis In an antibacterial assay using a panel of multidrug-resistant (MDR) strains, compounds 3 and 4 exhibited promising activity against the NorA efflux protein overexpressing MDR Staphylococcus aureus strain SA-1199B with a minimum inhibitory concentration (MIC) of 2 μg/mL (84 μM) and 4 μg/mL (168 μM), respectively The positive control antibiotic norfloxacin showed activity at MIC 32 μg/mL (100 μM)
55 citations
•
55 citations
••
TL;DR: The γ‐pyrones, artomunoxanthotrione epoxide, cyclocommunol, cyclomulberrin, and cyclocomunin exhibited potent inhibition of human PLC/PRF/5 and KB cells in‐vitro.
Abstract: The gamma-pyrones, artomunoxanthotrione epoxide, cyclocommunol, cyclomulberrin, and cyclocommunin exhibited potent inhibition of human PLC/PRF/5 and KB cells in-vitro. Dihydroisocycloartomunin showed significant and potent inhibition of human PLC/PRF/5 and KB cells in-vitro, respectively. Cyclomorusin, dihydrocycloartomunin and artomunoxanthone showed significant inhibition of KB cells in-vitro. Based on the above finding and the reported antileukaemic activity of xanthone psorospermin, a series of natural gamma-pyrones was prepared and the inhibition of human PLC/PRF/5 and KB cells in-vitro was measured. Structure-activity analysis indicated the epoxide group substituted at 3-hydroxyl and 2,6-; 3,6-; and 3,5-dihydroxyl xanthone enhanced the anti-tumour activity. The epoxide group substituted at the 6-hydroxyl group of 1,6-dihydroxyxanthone did not show anti-tumour activity.
54 citations
••
TL;DR: In this article, a regioselective cyclization of an intermediate benzophenone to a xanthone was shown to depend on cytochrome P450, as shown by the effectiveness of established P450 inhibitors.
Abstract: A crucial step in plant xanthone biosynthesis is the cyclization of an intermediate benzophenone to a xanthone In cultured cells of Centaurium erythraea RAFN, 2,3′,4,6-tetrahydroxybenzophenone (THBP) was shown to be intramolecularly coupled to 1,3,5-trihydroxyxanthone, whereas in cell cultures of Hypericum androsaemum L it was coupled to form the isomeric 1,3,7-trihydroxyxanthone These regioselective cyclizations that occur ortho and para, respectively, to the 3′-hydroxy group of the benzophenone depend on cytochrome P450, as shown by the effectiveness of established P450 inhibitors and blue-light-reversible carbon monoxide inhibition Furthermore, the reactions absolutely require NADPH and O2 The underlying reaction mechanism is probably an oxidative phenol coupling that is catalyzed regioselectively by xanthone synthases These enzymes are proposed to be cytochrome P450 oxidases The intramolecular cyclizations of THBP to 1,3,5- and 1,3,7-trihydroxyxanthones catalyzed by the two xanthone synthases represent an important branch point in the plant xanthone biosynthetic pathway
54 citations